Furthermore, when ciGEnCs were treated with 5% sera from LN patients, IL-1β levels secreted by the cells were below the level of detection for the assay (except for 1 active disease sera sample) (Fig. 4b). This evidence concerns the gene IL1B and lobular neoplasia.